Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01065506 · ClinicalTrials.gov registry record · Phase 3

Smoking Termination Enhancement Project (STEP)

A Phase 3 study, sponsored by Southern Methodist University.

Completed
Registry status
Phase 3
Development phase
150
Enrollment target

NCT01065506: Completed Phase 3 study, sponsored by Southern Methodist University.

NCT01065506 is a Phase 3 study that has completed, run by Southern Methodist University. The registered enrollment target is 150 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01065506, a Phase 3 study, has completed, sponsored by Southern Methodist University.

COMPLETED
Registry status
Phase 3
Development phase
150 participants
Enrollment target

Study Summary

The primary aim of this research study (STEP) is to compare the effectiveness of two smoking cessation programs that integrate counseling and nicotine replacement with either a wellness program or exercise. This will help us to determine whether different lifestyle interventions (wellness or exercise) help increase the effectiveness of current standard programs for smoking cessation.

Primary Outcome

Point Prevalence Abstinence (PPA) was defined as not smoking \[even a single puff\] at the end of treatment and/or on the day of follow-up

Interventions

  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Wellness Program
  • DRUG Nicotine Patch
  • BEHAVIORAL Cognitive Behavioral Treatment

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2009-09
Est. Completion 2013-08
Phase Phase 3
Southern Methodist University

17 total trials

What the finished NCT01065506 record still lists

NCT01065506 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 4 interventions - of which Aerobic Exercise is the first listed.

NCT01065506 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01065506 about?

NCT01065506 is a clinical study titled "Smoking Termination Enhancement Project (STEP)". The primary aim of this research study (STEP) is to compare the effectiveness of two smoking cessation programs that integrate counseling and nicotine replacement with either a wellness program or exercise. This will help us to determine whether different lifestyle interventions (wellness or exercis...

What is the current status of trial NCT01065506?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2009-09. Estimated completion is 2013-08.

What interventions are being tested in trial NCT01065506?

The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Wellness Program (BEHAVIORAL), Nicotine Patch (DRUG), Cognitive Behavioral Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01065506?

This trial is sponsored by Southern Methodist University, which has 17 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01065506's enrollment target sits among peer trials

150 1519th of 2000 higher than 455 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01065506, the US trial registry maintained by the National Library of Medicine. NCT01065506 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.